Under the Horseracing Safety and Integrity Act of 2020, the Horseracing Integrity and Welfare Unit, the independent enforcement agency of the Drug and Integrity Administration’s Drug and Anti-Doping Program of Horseracing, retains the authority to direct all trials in HISA-administered jurisdictions upon implementation of the ADMC Program, effective March 27.
For stock races to be classified and listed in the United States to maintain their respective status each year, one of the requirements is that the testing associated with these races must meet the Review Process. US Classified Stock Commission drug test for TCO2 and post-race testing.
In recognition of the powers granted to HIWU under the Act, the Purebred Breeders and Owners Association, which has established and administers the American Classification of Stocks Commission, will adopt procedures and standards. Tests administered by HIWU for classified and listed stock races are conducted at HISA. jurisdiction. HIWU will assign TCO2 and post-race checks to these races with race-specific amounts and rates.
Therefore, a track is not at risk of losing its graded or listed status for its races if the HIWU testing procedures for these races differ from those of the Classification Stock Commission. USA.
Races operating in states that are not under HISA jurisdiction will still be subject to the US Classified Stock Commission’s Drug Testing Protocols regarding maintaining classified and listed status. statistics of their races.
This press release has not been edited by BloodHorse. If you have any questions, please contact the organization that produced the release.
